The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The Ethics of Childhood Obesity Treatment - from the Childhood Obesity Task Force (COTF) of European Association for the Study of Obesity (EASO)
Open accessAbstract
With the American Medical Association's recent declaration that obesity is a serious disease [1], a critical consideration of the ethics of treating childhood obesity is especially timely. Although data suggest that the childhood obesity epidemic has stabilized in some countries [2], the levels remain too high; 18-49% of European children are overweight [3]. Consequently there is an immense and urgent need for the effective treatment of this complex disease. Unfortunately, the most recent Cochrane review concludes that, although family-based interventions can reduce excess weight in children and adolescents, long-term, effective and sustainable interventions for childhood obesity have yet to be identified [4]. Childhood obesity is a complex disease caused by a multitude of factors and it is associated with a wide range of co-morbidities. This complexity makes it challenging to design interventions and test the treatment approaches - particularly with regard to which outcome(s) should be used as the criteria for success. Most childhood obesity treatments occur in healthcare settings. As such, the randomized controlled trial (RCT), which is the ‘gold standard' of the medical/clinical research tradition, has been used to evaluate whether a given obesity treatment protocol is safe and effective. It is questionable however, if the RCT is the optimal study design to address this complex issue.Researchers investigating childhood obesity treatments face difficulties in deciding which outcomes best reflect the impact of treatment and, if a RCT is conducted, what type of treatment should it be randomized against. In light of the widespread childhood obesity epidemic, this paper will explore the ethical implications of these issues. Pediatric obesity research is conducted in a vulnerable group of patients and families. Many children who are obese suffer from significant psychological problems including anxiety, depression, attention-deficit hyperactivity as well as emotional and eating disorders [5,6]. Added to this, obesity carries a social stigma that adversely affects children as well as their families. There has been - and still is - considerable debate as to who bears the responsibility for the development of excess weight in the child and who bears the responsibility for alleviating the condition at the individual and the societal levels [7,8]. In recognition of these issues, there are discussions surrounding the ethics of community-based approaches of treating childhood obesity [9] and about mechanistic clinical studies aimed at understanding the pathophysiology of morbid obesity in children without a direct aim of reducing weight or the degree of obesity [10]. Less attention, however, has been given to the ethics of studying the individual treatment of the condition.The vast majority of childhood obesity therapy research is conducted at hospitals and their associated clinics or at universities. In this framework, treatment protocols are examined and approved by ethical review committees; thus it can be assumed that the basic premises of these studies are ethically acceptable. Nonetheless, investigators are obliged to ensure that their research fulfils the four basic principles of ethical research: respect for autonomy, beneficence, non-maleficence, and justice [11]. In the context of childhood obesity research, this can be challenging. Children who are obese and their families are often desperate for treatment because existing programs can have long waiting lists or be out of reach due to cost, time, and transportation factors.Given these circumstances, investigators must carefully consider if their protocol provides a situation in which they can scientifically test their hypotheses and balance this with creating a situation in which children and families freely make the choice to enter the study (autonomy), that the child receives a net benefit through participation in a timely manner (beneficence and non-maleficence), and that the exclusion criteria for participation are reasonable (justice). With these principles in mind, it becomes apparent that the development of treatment protocols must recognize the need for effective treatment along with consideration for the well-being of the child and his or her parent(s). The majority of childhood obesity treatments use the reduction of weight, BMI (kg/m2), waist circumference, and/or body composition as the primary outcome. These studies usually evaluate the change over a period of a few months to a maximum of a couple of years. Although weight loss or stabilization represents a reasonable target, it may be overly simplistic since childhood obesity is a complex phenotype that is associated with multiple concurrent co-morbidities. Clinical studies suggest that almost 50% of children who are obese exhibit pre- or grade 1 or 2 hypertension [12,13], another 29% have dyslipidemia [14], 44% have more than 5% fat in their livers [15], and 74% exhibit more than 5% fat in t
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Interventions for treating obesity in children
Oude Luttikhuis, H., Baur, L., Jansen, H., Shrewsbury, V. A., O'Malley, C., Stolk, R. P., & Summerbell, C. D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001872.pub2 · Cited by 1,531
RetractedCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_9 · Cited by 3,476
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Self-citationInterventions for preventing obesity in children
Brown, T., Moore, T. H., Hooper, L., Gao, Y., Zayegh, A., Ijaz, S., Elwenspoek, M., Foxen, S. C., Magee, L., O'Malley, C., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001871.pub4 · Cited by 2,982
Andrea, D., Kakuk, P., & Judit, S. (2014) · University of Debrecen Electronic Archive (University of Debrecen) · Cited by 1,954
Childhood Body-Mass Index and the Risk of Coronary Heart Disease in Adulthood
Baker, J. L., Olsen, L. W., & Sørensen, T. I. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072515 · Cited by 1,679
Self-citation
Research works printed but not linked: 2
- 10.1016/S0140-6736(03)14915-X · doi:10.1016/s0140-6736(03)14915-x
- 10.2223/JPED.2111 · DOI
Cited by
Understanding and misunderstanding randomized controlled trials
Deaton, A., & Cartwright, N. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.12.005 · Cited by 1,841
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
Carson, J. L., Stanworth, S. J., Roubinian, N., Fergusson, D. A., Triulzi, D., Doree, C., & Hebert, P. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002042.pub4 · Cited by 1,250
Hernán, M. A., Alonso, A., Logan, R., Grodstein, F., Michels, K. B., Willett, W. C., Manson, J. E., & Robins, J. M. (2008) · Epidemiology · doi:10.1097/ede.0b013e3181875e61 · Cited by 818
Stukel, T. A., Fisher, E. S., Wennberg, D. E., Alter, D. A., Gottlieb, D. J., & Vermeulen, M. J. (2007) · JAMA · doi:10.1001/jama.297.3.278 · Cited by 786
Weinstein, J. N., Lurie, J. D., Tosteson, T. D., Skinner, J. S., Hanscom, B., Tosteson, A. N. A., Herkowitz, H., Fischgrund, J., Cammisa, F. P., Albert, T., et al. (2006) · JAMA · doi:10.1001/jama.296.20.2451 · Cited by 764
Randomised trials in surgery: problems and possible solutions
McCulloch, P., Taylor, I., Sasako, M., Lovett, B., & Griffin, D. (2002) · BMJ · doi:10.1136/bmj.324.7351.1448 · Cited by 762
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Blonde, L., Khunti, K., Harris, S. B., Meizinger, C., & Skolnik, N. S. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0805-y · Cited by 714
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Medical big data: promise and challenges
Lee, C. H., & Yoon, H.-J. (2017) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2017.36.1.3 · Cited by 594
Influence of Resistance Exercise on Lean Body Mass in Aging Adults: A Meta-Analysis
PETERSON, M. D., SEN, A., & GORDON, P. M. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181eb6265 · Cited by 558
Anglemyer, A., Horvath, H. T., & Bero, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000034.pub2 · Cited by 534
Evidence, hierarchies, and typologies: horses for courses: Table 1
Petticrew, M., & Roberts, H. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.7.527 · Cited by 539
Randomisation to protect against selection bias in healthcare trials
Odgaard-Jensen, J., Vist, G. E., Timmer, A., Kunz, R., Akl, E. A., Schünemann, H., Briel, M., Nordmann, A. J., Pregno, S., & Oxman, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000012.pub3 · Cited by 439
Wang, S. V., Schneeweiss, S., Initiative, R.-D., Franklin, J. M., Desai, R. J., Feldman, W., Garry, E. M., Glynn, R. J., Lin, K. J., Paik, J., et al. (2023) · JAMA · doi:10.1001/jama.2023.4221 · Cited by 428
Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis
Ades, A. E., Sculpher, M., Sutton, A., Abrams, K., Cooper, N., Welton, N., & Lu, G. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00001 · Cited by 420
Tiihonen, J., Walhbeck, K., Lönnqvist, J., Klaukka, T., Ioannidis, J. P. A., Volavka, J., & Haukka, J. (2006) · BMJ · doi:10.1136/bmj.38881.382755.2f · Cited by 385
Which clinical studies provide the best evidence?
Barton, S. (2000) · BMJ · doi:10.1136/bmj.321.7256.255 · Cited by 384
Atsuta, Y. (2016) · International Journal of Hematology · doi:10.1007/s12185-015-1894-x · Cited by 357
Ochen, Y., Beks, R. B., van Heijl, M., Hietbrink, F., Leenen, L. P. H., van der Velde, D., Heng, M., van der Meijden, O., Groenwold, R. H. H., & Houwert, R. M. (2019) · BMJ · doi:10.1136/bmj.k5120 · Cited by 351
Get real in individual participant data (IPD) meta‐analysis: a review of the methodology
Debray, T. P. A., Moons, K. G. M., van Valkenhoef, G., Efthimiou, O., Hummel, N., Groenwold, R. H. H., Reitsma, J. B., & on behalf of the GetReal methods review group (2015) · Research Synthesis Methods · doi:10.1002/jrsm.1160 · Cited by 348
Characterizing treatment pathways at scale using the OHDSI network
Hripcsak, G., Ryan, P. B., Duke, J. D., Shah, N. H., Park, R. W., Huser, V., Suchard, M. A., Schuemie, M. J., DeFalco, F. J., Perotte, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510502113 · Cited by 326
Transfusion thresholds for guiding red blood cell transfusion
Carson, J. L., Stanworth, S. J., Dennis, J. A., Trivella, M., Roubinian, N., Fergusson, D. A., Triulzi, D., Dorée, C., & Hébert, P. C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002042.pub5 · Cited by 322
Issues in the reporting of epidemiological studies: a survey of recent practice.
Pocock, S. J., Collier, T. J., Dandreo, K. J., de Stavola, B. L., Goldman, M. B., Kalish, L. A., Kasten, L. E., & McCormack, V. A. (2004) · BMJ · doi:10.1136/bmj.38250.571088.55 · Cited by 313
Stürmer, T., Wyss, R., Glynn, R. J., & Brookhart, M. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12197 · Cited by 302
Franklin, J. M., Patorno, E., Desai, R. J., Glynn, R. J., Martin, D., Quinto, K., Pawar, A., Bessette, L. G., Lee, H., Garry, E. M., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051718 · Cited by 299
Haynes, R. B. (2002) · BMC Health Services Research · doi:10.1186/1472-6963-2-3 · Cited by 296
Pratt, M., Sarmiento, O. L., Montes, F., Ogilvie, D., Marcus, B. H., Perez, L. G., & Brownson, R. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60736-3 · Cited by 295
Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
Gershenson, D. M., Bodurka, D. C., Coleman, R. L., Lu, K. H., Malpica, A., & Sun, C. C. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0632 · Cited by 279
Gatta, L., & Scarpignato, C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13928 · Cited by 266
Lagier, J.-C., Million, M., Gautret, P., Colson, P., Cortaredona, S., Giraud-Gatineau, A., Honoré, S., Gaubert, J.-Y., Fournier, P.-E., Tissot-Dupont, H., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101791 · Cited by 254
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
Papanikolaou, P. N. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050873 · Cited by 229
Surgical versus conservative treatment for lumbar disc herniation: a prospective cohort study
Gugliotta, M., da Costa, B. R., Dabis, E., Theiler, R., Jüni, P., Reichenbach, S., Landolt, H., & Hasler, P. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012938 · Cited by 215
Dahabreh, I. J., Sheldrick, R. C., Paulus, J. K., Chung, M., Varvarigou, V., Jafri, H., Rassen, J. A., Trikalinos, T. A., & Kitsios, G. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs114 · Cited by 204
The musculoskeletal diagnosis cohort: examining pain and pain care among veterans
Goulet, J. L., Kerns, R. D., Bair, M., Becker, W. C., Brennan, P., Burgess, D. J., Carroll, C. M., Dobscha, S., Driscoll, M. A., Fenton, B. T., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000567 · Cited by 174
Target Validity and the Hierarchy of Study Designs
Westreich, D., Edwards, J. K., Lesko, C. R., Cole, S. R., & Stuart, E. A. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwy228 · Cited by 165
Ghimire, S., Kyung, E., Kang, W., & Kim, E. (2012) · Trials · doi:10.1186/1745-6215-13-77 · Cited by 140
Harnessing big data to characterize immune-related adverse events
Jing, Y., Yang, J., Johnson, D. B., Moslehi, J. J., & Han, L. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00597-8 · Cited by 125
McGovern, M. E., & Canning, D. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv125 · Cited by 122
Accelerating clinical evidence synthesis with large language models
Wang, Z., Cao, L., Danek, B., Jin, Q., Lu, Z., & Sun, J. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01840-7 · Cited by 69
Toews, I., Anglemyer, A., Nyirenda, J. L., Alsaid, D., Balduzzi, S., Grummich, K., Schwingshackl, L., & Bero, L. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000034.pub3 · Cited by 60
Bigna, J. J. R., Um, L. N., & Nansseu, J. R. N. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0356-8 · Cited by 51
Carleton, R. N., Krätzig, G. P., Sauer-Zavala, S., Neary, J. P., Lix, L. M., Fletcher, A. J., Afifi, T. O., Brunet, A., Martin, R., Hamelin, K. S., et al. (2022) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.42.8.02 · Cited by 45
Xu, C., Fan, S., Tian, Y., Liu, F., Furuya-Kanamori, L., Clark, J., Zhang, C., Li, S., Lin, L., Chu, H., et al. (2025) · BMJ · doi:10.1136/bmj-2024-082068 · Cited by 39
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study
Groot, P. C., & van Os, J. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211039327 · Cited by 38
Efficacy of antidepressants in child and adolescent depression: a meta-analytic study
Papanikolaou, K., Richardson, C., Pehlivanidis, A., & Papadopoulou-Daifoti, Z. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0340-2 · Cited by 38
Treatment effect prediction with adversarial deep learning using electronic health records
Chu, J., Dong, W., Wang, J., He, K., & Huang, Z. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01151-9 · Cited by 24
Vercellini, P., Somigliana, E., Cortinovis, I., Bracco, B., de Braud, L., Dridi, D., & Milani, S. (2015) · BMC Women's Health · doi:10.1186/s12905-015-0248-4 · Cited by 22
Khan, M. S., Shaikh, A., Ochani, R. K., Akhtar, T., Fatima, K., Khan, S. U., Mookadam, F., Murad, M. H., Figueredo, V. M., Doukky, R., et al. (2019) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005260 · Cited by 21
Hua, F., Sun, Q., Zhao, T., Chen, X., & He, H. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029270 · Cited by 20
Metadata
- Authors
- Holm, J. C., Nowicka, P., Farpour-Lambert, N. J., O'Malley, G., Hassapidou, M., Weiss, R., & Baker, J. L.
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 7
- Issue
- 4
- Pages
- 274-281
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- OpenAlex
- W1580457945
- Cited by
- 592
- References
- 37
- FWCI
- 45.35
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.